Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)

NCT03745378 is registered in ClinicalTrials.gov with FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS as lead sponsor.

NCT NCT03745378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03745378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)
Lead sponsor
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Phase
Observational
Overall status
Completed
Start date
May 15, 2018
Completion date
September 30, 2018
Enrollment
1,881 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

essential thrombocythemia, myelofibrosis, polycythemia vera